Saturday 21 December 2024
Salisbury Foundation Trust

FOI_7162

Internal Reference Number: FOI_7162

Date Request Received: 02/05/2023 00:00:00

Date Request Replied To: 17/05/2023 00:00:00

This response was sent via: By Email

Request Summary: Biologic and biosimilar products - Rheumatology

Request Category: Companies

 
Question Number 1:
Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs:

• Abatacept [Orencia]

• Adalimumab [Humira]

• Adalimumab Biosimilars

• Apremilast [Otezla]

• Baricitinib [Olumiant]

• Certolizumab [Cimzia]

• Etanercept [Enbrel]

• Etanercept Biosimilars

• Filgotinib [Jyseleca]

• Golimumab [Simponi]

• Guselkumab [Tremfya]

• Infliximab [Remicade]

• Infliximab Biosimilars

• Ixekizumab [Taltz]

• Risankizumab [Skyrizi]

• Rituximab [MabThera]

• Rituximab Biosimilars

• Sarilumab [Kevzara]

• Secukinumab [Cosentyx]

• Tocilizumab [Ro Actemra]

• Tofacitinib [Xeljanz]

• Upadacitinib [Rinvoq]

• Ustekinumab [Stelara]
 
Answer To Question 1:
Abatacept 7
Adalimumab - Biosimilars 35
Humira 0
Apremilast 0
Baricitinib 8
Certolizumab <5
Enbrel 0
Etanercept biosimilars 22
Filgotinib 7
Golimumab <5
Guselkumab <5
Infliximab biosimilars <5
Remicade 0
Ixekizumab <5
Risankizumab 0
Mabthera 0
Rituximab biosimilars <5
Sarilumab 0
Secukinumab <5
Tocilizumab <5
Tofacitinib <5
Upadacitinib 14
Ustekinumab <5
 
Question Number 2:
Could you please provide the numbers of patients treated for Axial Spondyloarthritis ONLY in the last 3 months with the following drugs.

• Adalimumab [Humira]

• Adalimumab Biosimilars

• Certolizumab [Cimzia]

• Etanercept [Enbrel]

• Etanercept Biosimilars

• Golimumab [Simponi]

• Infliximab [Remicade]

• Infliximab Biosimilars

• Ixekizumab [Taltz]

• Secukinumab [Cosentyx]

• Tofacitinib [Xeljanz]

• Upadacitinib [Rinvoq]
 
Answer To Question 2:
For Axial Spondyloarthritis we have :

Adalimumab biosimilars <5
Certolizumab <5
Etranercept biosimilars <5
Infliximab biosimilars <5
Secukinumab <5
Upadacitinib <5
 
To return to the list of all the FOI requests please click here

Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.

Person Centred & Safe

Professional

Responsive

Friendly

Progressive

Salisbury NHS Foundation Trust, Salisbury District Hospital, Odstock Road, Salisbury, Wiltshire, SP2 8BJ
T: 01722 336262 E: sft.pals@nhs.net
© 2024 Salisbury NHS Foundation Trust
Trust Values